MR Imaging in Multiple Sclerosis: Review and Recommendations for Current Practice

被引：71

作者：

Loevblad, K.-O. ^{[1
]}

Anzalone, N. ^{[2
]}

Doerfler, A. ^{[4
]}

Essig, M. ^{[5
]}

Hurwitz, B. ^{[6
]}

Kappos, L. ^{[7
]}

Lee, S. -K. ^{[8
]}

Filippi, M. ^{[3
]}

机构：

[1] Univ Hosp Geneva, Diagnost Neuroradiol Unit, Dept Radiol, CH-1211 Geneva 14, Switzerland

[2] Ist Sci San Raffaele, Dept Neuroradiol, I-20132 Milan, Italy

[3] Ist Sci San Raffaele, Neuroimaging Res Unit, Dept Neurol, I-20132 Milan, Italy

[4] Univ Erlangen Nurnberg, Dept Neuroradiol, Erlangen, Germany

[5] German Canc Res Ctr, Dept Radiol, D-6900 Heidelberg, Germany

[6] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA

[7] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland

[8] Yonsei Univ, Coll Med, Dept Radiol, Seoul, South Korea

来源：

AMERICAN JOURNAL OF NEURORADIOLOGY | 2010年 / 31卷 / 06期

关键词：

NEPHROGENIC SYSTEMIC FIBROSIS; CLINICALLY ISOLATED SYNDROMES; 1ST DEMYELINATING EVENT; CONTRAST AGENTS; GADOBENATE-DIMEGLUMINE; DIAGNOSTIC-CRITERIA; GLATIRAMER ACETATE; ENHANCING LESIONS; DOSE GADOTERIDOL; NATURAL-HISTORY;

D O I：

10.3174/ajnr.A1906

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

MR imaging is widely used for the diagnosis and monitoring of patients with MS. Applications and protocols for MR imaging continue to evolve, prompting a need for continual reassessments of the optimal use of this technique in clinical practice. This article provides updated recommendations on the use of MR imaging in MS, based on a review of the trial evidence and personal experiences shared at a recent expert meeting of radiologists and neurologists.

引用

页码：983 / 989

页数：7

共 58 条

[11] MRI as an outcome in multiple sclerosis clinical trials [J].

Daumer, M. ;

Neuhaus, A. ;

Morrissey, S. ;

Hintzen, R. ;

Ebers, G. C. .

NEUROLOGY, 2009, 72 (08) :705-711

[12] Enhancing lesions of the brain: Intraindividual crossover comparison of contrast enhancement after gadobenate dimeglumine versus established gadolinium comparators [J].

Essig, Marco ;

Tartaro, Armando ;

Tartaglione, Tomasso ;

Pirovano, Gianpaolo ;

Kirchin, Miles A. ;

Spinazzi, Alberto .

ACADEMIC RADIOLOGY, 2006, 13 (06) :744-751

[13] A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis -: Implications for phase II clinical trials [J].

Filippi, M ;

Rovaris, M ;

Capra, R ;

Gasperini, C ;

Yousry, TA ;

Sormani, MP ;

Prandini, F ;

Horsfield, MA ;

Martinelli, V ;

Bastianello, S ;

Kühne, I ;

Pozzilli, C ;

Comi, G .

BRAIN, 1998, 121 :2011-2020

[14] Glatiramer acetate reduces the proportion of new MS lesions evolving into "black holes" [J].

Filippi, M ;

Rovaris, M ;

Rocca, MA ;

Sormani, MP ;

Wolinsky, JS ;

Comi, G .

NEUROLOGY, 2001, 57 (04) :731-733

[15] Disability and T2 MRI lesions:: a 20-year follow-up of patients with relapse onset of multiple sclerosis [J].

Fisniku, L. K. ;

Brex, P. A. ;

Altmann, D. R. ;

Miszkiel, K. A. ;

Benton, C. E. ;

Lanyon, R. ;

Thompson, A. J. ;

Miller, D. H. .

BRAIN, 2008, 131 :808-817

[16] Stability of Gadolinium-Based Magnetic Resonance Imaging Contrast Agents in Human Serum at 37°C [J].

Frenzel, Thomas ;

Lengsfeld, Philipp ;

Schirmer, Heiko ;

Huetter, Joachim ;

Weinmann, Hanns-Joachim .

INVESTIGATIVE RADIOLOGY, 2008, 43 (12) :817-828

[17]

Fujihara Kazuo, 2005, Int MS J, V12, P34

[18]

Ge Y, 2006, AM J NEURORADIOL, V27, P1165

[19]

Ge YL, 2005, AM J NEURORADIOL, V26, P2316

[20] Neuroinflammation in multiple sclerosis: Evidence for autoimmune dysregulation, not simple autoimmune reaction [J].

Grigoriadis, N ;

Grigoriadis, S ;

Polyzoidou, E ;

Milonas, I ;

Karussis, D .

CLINICAL NEUROLOGY AND NEUROSURGERY, 2006, 108 (03) :241-244

← 1 2 3 4 5 6 →